Affiliation: University of Giessen
- Ewald N, Bretzel R. Diabetes mellitus secondary to pancreatic diseases (Type 3c)--are we neglecting an important disease?. Eur J Intern Med. 2013;24:203-6 pubmed publisher..Since most patients with T3cDM suffer from chronic pancreatitis, physicians must additionally be aware of the elevated risk of pancreatic cancer in this subset of patients. ..
- Ewald N, Kaufmann C, Raspe A, Kloer H, Bretzel R, Hardt P. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338-42 pubmed publisher..Yet, the right classification of diabetes mellitus is important, because there are special therapeutic options and problems in patients with diabetes secondary to pancreatic diseases. ..
- Ewald N, Bretzel R, Fantus I, Hollenhorst M, Kloer H, Hardt P. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev. 2007;23:386-91 pubmed..Pancreatin therapy can be used safely in patients with diabetes mellitus and exocrine dysfunction. Parameters of glucose metabolism were not improved by enzyme replacement therapy. ..